is ro still selling semaglutide The Weight Loss Drug Market Has Gotten Messy. What to Know Ro has tied itself to

Enforcement Discretion Period While the legal proceedings are ongoing, the FDA has exercised enforcement discretion, allowing compounding pharmacies to continue producing semaglutide until the later of the established deadlines or the date of the district court's decision on the preliminary injunction motion in the OFA v

This is often called combination therapy

Its subsequent November 8, 2023 approval as Zepbound for chronic weight management extended these benefits to people with obesity or overweight plus comorbidity

District Court for the Northern District of Texas ruled that compounding pharmacies could no longer make and sell their own versions of semaglutide

Lindenfeld J, Zile MR, Desai AS, et al